Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis

Neuroendocrinology

Volumn 97, Issue 2, 2013, Pages 160-175

  Washburn, Neal ^a   Borgquist, Amanda ^a   Wang, Kate ^a   Jeffery, Garrett S ^a   Kelly, Martin J ^b   Wagner, Edward J ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Appetite; Cannabinoids; Estrogen; Proopiomelanocortin; Protein kinase A; Protein kinase C

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL BENZOATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY HOMEOSTASIS; ENZYME INHIBITION; EXPERIMENTAL GUINEA PIG; FEMALE; FOOD INTAKE; HYPERPHAGIA; HYPOTHERMIA; LUNG GAS EXCHANGE; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP TECHNIQUE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; BENZOXAZINES; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EATING; ENERGY METABOLISM; ESTROGENS; FEMALE; GUINEA PIGS; HOMEOSTASIS; MORPHOLINES; NAPHTHALENES; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 84876292152     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000338669     Document Type: Article

References (70)

1. Qiu J, Rønnekleiv OK, Kelly MJ: Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen receptor. Steroids 2008; 73: 985-991.
2. Boulware MI, Kordasiewicz H, Mermelstein PG: Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J Neurosci 2007; 27: 9941-9950.
3. Dewing P, Christensen A, Bondar G, Micevych PE: Protein kinase C signaling in the hypothalamic arcuate nucleus regulates sexual receptivity in female rats. Endocrinology 2008; 149: 5934-5942.
4. Matsuoka H, Tsubaki M, Yamazoe Y, Ogaki M, Satou T, Itoh T, Kusunoki T, Nishida S: Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/ Akt pathways. Exp Cell Res 2009; 315: 2022-2032.
5. Li L, Haynes P, Bender JR: Plasma membrane localization and function of the estrogen receptorαvariant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 2003; 100: 4807-4812.
6. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG: Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 2005; 25: 5066-5078.
7. Jeffery GS, Peng KC, Wagner EJ: The role of phosphatidylinositol-3-kinase and AMP-activated kinase in the rapid estrogenic attenuation of cannabinoid-induced changes in energy homeostasis. Pharmaceuticals 2011; 4: 630-651.
8. Kuo J, Hamid N, Bondar G, Prossnitz ER, Micevych PE: Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J Neurosci 2010; 30: 12950-12957.
9. Gingerich S and Krukoff TL: Activation of ERβ increases levels of phosphorylated nNOS and NO production through a Src/ PI3K/Akt-dependent pathway in hypothalamic neurons. Neuropharmacology 2008; 55: 878-885.
10. Chu Z, Andrade J, Shupnik MA, Moenter SM: Differential regulation of gonadotropinreleasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype. J Neurosci 2009; 29: 5616-5627.
11. Michaeli A, Yaka R: Dopamine inhibits GABA A currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels. Neuroscience 2010; 165: 1159-1169.
12. Lebesgue D, Reyna-Neyra A, Huang X, Etgen AM: GPR30 differentially regulates short latency responses of luteinizing hormone and prolactin secretion to oestradiol. J Neuroendocrinol 2009; 21: 743-752.
13. Xu H, Qin S, Carrasco GA, Dai Y, Filardo EJ, Prossnitz ER, Battaglia G, DonCarlos LL, Muma NA: Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 2009; 158: 1599-1607.
14. Toran-Allerand CD: Estrogen and the brain: beyond ER-α, ER-β, and 17β-estradiol. Ann NY Acad Sci 2005; 1052: 136-144.
15. Butera PC, Czaja JA: Intracranial estradiol in ovariectomized guinea pigs: effects on ingestive behaviors and body weight. Brain Res 1984; 322: 41-48.
16. Johnson WG, Corrigan SA, Lemmon CR, Bergeron KB, Crusco AH: Energy regulation over the menstrual cycle. Physiol Behav 1994; 56: 523-527.
17. Stephenson LA, Kolka MA: Esophageal temperature threshold for sweating decreases before ovulation in premenopausal women. J Appl Physiol 1999; 86: 22-28.
18. Roepke TA, Bosch MA, Rick EA, Lee B, Wagner EJ, Seidlova-Wuttke D, Wuttke W, Scanlan TS, Rønnekleiv OK, Kelly MJ: Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis. Endocrinology 2010; 151: 4926-4937.
19. Farhang B, Diaz S, Tang SL, Wagner EJ: Sex differences in the cannabinoid regulation of energy homeostasis. Psychoneuroendocrinology 2009; 34S:S237-S246.
20. Kellert BA, Nguyen MC, Nguyen C, Nguyen QH, Wagner EJ: Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis. Eur J Pharmacol 2009; 622: 15-24.
21. Riebe CJN, Hill MN, Lee TTY, Hillard CJ, Gorzalka BB: Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrinology 2010; 35: 1265-1269.
22. Santollo J, Wiley MD, Eckel LA: Acute activation of ERβ decreases food intake, meal size and body weight in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2007; 293:R2194-R2201.
23. Lindsey SH, Yamaleyeva LM, Brosnihan KB, Gallagher PE, Chappell MC: Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2. Lewis rat. Hypertension 2011; 58: 665-671.
24. Tindal JS: The forebrain of the guinea pig in stereotaxic coordinates. J Comp Neurol 1965; 124: 259-266.
25. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Rønnekleiv OK, Kelly MJ: Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 2003; 23: 9529-9540.
26. Chang A, Li PP, Warsh JJ: cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Mol Brain Res 2003; 116: 27-37.
27. Roepke TA, Malyala A, Bosch MA, Kelly MJ, Rønnekleiv OK: Estrogen regulation of genes important for K + channel signaling in the arcuate nucleus. Endocrinology 2007; 148: 4937-4951.
28. Malyala A, Zhang C, Bryant DN, Kelly MJ, Rønnekleiv OK: PI3K signaling effects in hypothalamic neurons mediated by estrogen. J Comp Neurol 2008; 506: 895-911.
29. Roepke TA, Xue C, Bosch MA, Scanlan TS, Kelly MJ, Rønnekleiv OK: Genes associated with membrane-initiated signaling of estrogen and energy homeostasis. Endocrinology 2008; 149: 6113-6124.
30. Kelly MJ, Moss RL, Dudley CA, Fawcett CP: The specificity of the response of preopticseptal area neurons to estrogen: 17β-estradiol versus 17β-estradiol and the response of extrahypothalamic neurons. Exp Brain Res 1977; 30: 43-52.
31. Sullivan JP, Connor JR, Shearer BG, Burch RM: 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain. Mol Pharmacol 1992; 41: 38-44.
32. Gadbois DM, Crissman HA, Tobey RA, Bradbury EM: Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci USA 1992; 89: 8626-8630.
33. Lagrange AH, Ronnekleiv OK, Kelly MJ: Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol Pharmacol 1997; 51: 605-612.
34. Nguyen QH, Wagner EJ: Estrogen differentially modulates the cannabinoid-induced presynaptic inhibition of amino acid neurotransmission in proopiomelanocortin neurons of the arcuate nucleus. Neuroendocrinology 2006; 84: 123-137.
35. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R: Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 2009; 214: 67-77.
36. Intapad S, Dimitropoulou C, Snead C, Piyachaturawat P, Catravas JD: Regulation of asthmatic airway relaxation by estrogen and heat shock protein 90. J Cell Physiol 2012; 227: 3036-3043.
37. Mattes RD, Engelman K, Shaw LM, Elsohly MA: Cannabinoids and appetite stimulation. Pharmacol Biochem Behav 1994; 49: 187-195.
38. Budney AJ, Hughes JR, Moore BA, Novy PL: Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 2001; 58: 917-924.
39. Williams CM, Rogers PJ, Kirkham TC: Hyperphagia in pre-fed rats following oralΔ9 -THC. Physiol Behav 1998; 65: 343-346.
40. Koch JE:Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 2001; 68: 539-543.
41. Sinnayah P, Jobst EE, Rathner JA, Caldera-Siu AD, Tonelli-Lemos L, Eusterbrock AJ, Enriori PJ, Pothos EN, Grove KL, Cowley MA: Feeding induced by cannabinoids is mediated independently of the melanocortin system. PLoS ONE 2008; 3:e2202.
42. Hentges ST, Low MJ, Williams JT: Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 2005; 25: 9746-9751.
43. Ho J, Cox JM, Wagner EJ: Cannabinoidinduced hyperphagia: correlation with inhibition of proopiomelanocortin neurons? Physiol Behav 2007; 92: 507-519.
44. Glavas MM, Joachim SE, Draper SJ, Smith MS, Grove KL: Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. Endocrinology 2007; 148: 3279-3287.
45. Verty ANA, Allen AM, Oldfield BJ: The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat. Endocrinology 2010; 151: 4236-4246.
46. Verty ANA, Allen AM, Oldfield BJ: The effects of Rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity 2008; 17: 254-261.
47. Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, Bechmann I, Leranth C, Toran-Allerand D, Priest CA, Roberts JL, Gao X-B, Mobbs C, Shulman GI, Diano S, Horvath TL: Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med 2007; 13: 89-94.
48. Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG, Ogawa S: Silencing of estrogen receptor α in the ventromedial nucleus of the hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 2007; 104: 2501-2506.
49. Dominguez R, Micevych PE: Estradiol rapidly regulates membrane estrogen receptor alpha; levels in hypothalamic neurons. J Neurosci 2010; 30: 12589-12596.
50. Dhillon SS, Belsham DD: Estrogen inhibits NPY secretion through membrane-associated estrogen receptor (ER)-alpha; in clonal, immortalized hypothalamic neurons. Int J Obesity 2011; 35: 198-207.
51. Horvath TL: The hardship of obesity: a softwired hypothalamus. Nat Neurosci 2005; 8: 561-565.
52. Sternson SM, Shepherd GMG, Friedman JM: Topographic mapping of VMH-arcuate nucleus microcircuits and their reorganization by fasting. Nat Neurosci 2005; 8: 1356-1363.
53. Schuman EM, Madison DV: A requirement for the intracellular messenger nitric oxide in long-term potentiation. Science 1991; 254: 1503-1506.
54. Tseng AH, Craft RM: Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 2001; 430: 41-47.
55. Tseng AH, Harding JW, Craft RM: Pharmacokinetic factors in sex differences Δ9-tetrahydrocannabinol-induced behavioral effects in rats. Behav Brain Res 2004; 154: 77-83.
56. Wiley JL: Sex-dependent effects ofΔ9-tetrahydrocannabinol on locomotor activity in mice. Neurosci Lett 2003; 352: 77-80.
57. Craft RM, Leitl MD: Gonadal hormone modulation of the behavioral effects ofΔ9-tetrahydrocannabinol in male and female rats. Eur J Pharmacol 2008; 578: 37-42.
58. Mathew RJ, Wilson WH, Davis R: Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics. Pharmacol Biochem Behav 2003; 75: 309-318.
59. Pope HG, Jacobs A, Mialet J-P, Yurgelun-Todd D, Gruber S: Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 1997; 66: 179-184.
60. Biscaia M, Mark GP, Fernández B, Marco EM, Rubio M, Guaza C, Ambrosio E, Viveros MP: Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioral responses of male and female rats. Psychopharmacology (Berl) 2003; 170: 301-308.
61. Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C, Cherubino F, Romualdi P, Candeletti S, Sala M, Parolaro D: ChronicΔ9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 2008; 33: 2760-2771.
62. Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, Castelli MP, Viveros M-P: Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces genderdependent long-lasting memory impairments and changes in brain nicotinic and CB 1 receptors. J Psychopharmacol 2011; 25: 1676-1690.
63. Miller CC, Murray TF, Freeman KG, Edwards GL: Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 2004; 80: 611-616.
64. Diano S, Naftolin F, Horvath TL: Gonadal steroids target AMPA glutamate receptorcontaining neurons in the rat hypothalamus, septum and amygdala: a morphological and biochemical study. Endocrinology 1997; 138: 778-789.
65. Eckersell CB, Popper P, Micevych PE: Estrogen-induced alteration of μ -opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. J Neurosci 1998; 18: 3967-3976.
66. Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A: Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 2005; 29: 358-367.
67. Haney M, Rabkin J, Gunderson E, Foltin RW: Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 2005; 181: 170-178.
68. Walsh D, Kirkova J, Davis MP: The efficacy and tolerability of long-term use of dronabinol in cancer-related anorexia: a case series. J Pain Symptom Manage 2005; 30: 493-495.
69. Lynch ME, Young J, Clark AJ: A case series of patients using medical marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations. J Pain Symptom Manage 2006; 32: 497-501.
70. Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-study-group. J Clin Oncol 2006; 24: 3394-3400.